Gerresheimer AG announces key data for IPO

Düsseldorf (ots) -

This press release or the information contained herein is not
being issued and may not be distributed in the United States of
America, Canada, Japan or Australia.

- Price range for Gerresheimer shares set at EUR 37 to EUR 45

- Planned offering comprises up to 22 million shares (plus
over-allotment option of a further 3.3 million shares)

- Start of trading on the Official Market (Prime Standard) of the
Frankfurt Stock exchange set for 11 June 2007

Gerresheimer AG, a leading worldwide manufacturer of high-quality
specialty-glass and plastic products for the pharmaceutics and life
science industry announces today the key terms of its initial public
offer. The price range has been set by the company and the offering
shareholder BCP Murano II S.à r.l. together with the Joint Global
Coordinators and Joint Bookrunners Credit Suisse and Morgan Stanley
at EUR 37 to EUR 45.

The offering comprises up to 11.4 million shares from a capital
increase and up to 10.6 million shares from the existing holding of
the selling shareholder BCP Murano II S.à r.l., which is furthermore
providing up to 3.3 million shares for an additional allocation
option. BCP Murano II S.à r.l., an affiliate of The Blackstone Group
International Limited, currently holds 100% of the shares in
Gerresheimer AG. If the over-allotment option is fully taken up, a
free float of 80.6% would be the result.

"Over recent years we have turned Gerresheimer into one of the
market leaders in the field of specialty-glass and plastic products
for the pharma and life science industry and are now ready for the
stock market," says Dr. Axel Herberg, CEO of Gerresheimer AG.

The shares of Gerresheimer AG are offered in a public offering in
Germany as well as an international private placement with
international investors outside Germany. The subscription period
commences on 29 May and will probably end on 8 June 2007. "As a
leading worldwide partner for the pharma and life science industry we
wish to continue our growth strategy consistently. The IPO is
intended to allow us to speed up our organic growth through targeted
acquisitions," says Herberg. The road show for institutional
investors in Germany, in rest of Europe and in the USA starts on 29
May and will probably end on 8 June.

The shares in Gerresheimer AG will be trading on the Official
Market (Prime Standard) of the Frankfurt Stock Exchange under the
stock-exchange abbreviation "GXI" and the ISIN "DE000A0LD6E6",
probably from 11 June 2007. In addition to Credit Suisse and Morgan
Stanley as Joint Global Coordinators and Joint Bookrunners, the
syndicate includes ABN AMRO Rothschild, Cazenove and Dresdner
Kleinwort as Co-Lead Managers.

Gerresheimer currently employs around 9,000 people in 31 locations
in Europe, America and Asia. The product range comprises medicine
bottles made of glass and plastic as well as complex drug delivery
systems. The latter include for example prefillable sterile syringes,
inhalers and other system solutions for safe dosage and application
of medications. The Group has a leading position in a market
characterised by technical and regulatory entry barriers as
Gerresheimer's products must meet the highest quality requirements of
the international pharmaceutical supervision authorities.

The Group achieved sales of around EUR 893 million in 2006 on a
pro-forma basis, of which around EUR 247 million was attributable to
the recently acquired Wilden AG, a European market and technology
leader for innovative plastic systems. Pro-forma adjusted EBITDA for
the Group in 2006 totalled around EUR 151 million. In the financial
year 2007, sales for the - traditionally weakest - first quarter were
around EUR 226 million and pro-forma adjusted EBITDA around EUR 40
million.

The information contained herein serves information purposes and
does not constitute any offer for sale or subscription of or
solicitation or invitation of any offer to buy or subscribe for any
securities. Securities will solely be offered on the basis of a
prospectus or other offering circular to be issued by the company in
connection with such offering. Any such German prospectus or offering
circular will be available free of charge as of 25 May 2007 for
persons outside of the United States from the Gerresheimer website
under www.gerresheimer.com as well as from Gerresheimer AG and the
Global Coordinators.

This press release does not constitute an offer to sell
securities, or a solicitation of an offer to buy securities, into the
United States. The securities of Gerresheimer AG described herein
have not been and will not be registered under the U.S. Securities
Act of 1933, as amended (the "Securities Act"), or the laws of any
State, and may not be offered or sold within the United States,
except pursuant to an exemption from, or in a transaction not subject
to, the registration requirements of the Securities Act and
applicable State laws. Neither Gerresheimer AG nor any selling
shareholder intends to register any portion of the offering in the
United States or conduct a public offering of securities in the
United States.

This communication is directed only at (I) persons who are outside
the United Kingdom or (II) persons having professional experience in
matters relating to investments or (III) high net worth companies and
other persons to whom it may lawfully be committed falling within
article 49(2)(a) to (d) of the Financial Services and Markets Act
2000 (Financial Promotion) Order 2005 (as amended) (all such persons
together being referred to as "Relevant Persons"). Any person who is
not a Relevant Person must not act or rely on this communication or
any of its contents. Any investment or investment activity to which
this communication relates is available only to Relevant Persons and
will be engaged in only with Relevant Persons.

Originaltext: Gerresheimer Group
digital press kits: http://presseportal.de/story.htx?firmaid=9072
press kits via RSS: feed://presseportal.de/rss/pm_9072.rss2
ISIN: DE0005873004

Contact:
Burkhard Lingenberg
Director Corporate PR & Marketing
Gerresheimer AG
Tel. +49-(0)211/6181-251
b.lingenberg@gerresheimer.com